Unleashing the potential: the imperative of political support for health technology assessment in Iran.
Evidence-based decision-making
Health policy
Health technology assessment
Healthcare system
Iran
Political support
Journal
Health economics review
ISSN: 2191-1991
Titre abrégé: Health Econ Rev
Pays: Germany
ID NLM: 101583209
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
16
08
2023
accepted:
24
09
2024
medline:
8
10
2024
pubmed:
8
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
Health Technology Assessment (HTA) is essential for evidence-based healthcare decision-making, yet its integration into Iran's healthcare system faces political and logistical challenges. Despite HTA's potential to improve resource allocation, limited awareness, data gaps, and competing priorities hinder its implementation. This commentary emphasizes the need for political support, advocating capacity-building, collaboration, and alignment with long-term health policies. Leveraging international partnerships and monitoring outcomes can enhance HTA's role in improving healthcare in Iran and contributing to global health advancements.
Identifiants
pubmed: 39378013
doi: 10.1186/s13561-024-00563-x
pii: 10.1186/s13561-024-00563-x
doi:
Types de publication
Letter
Langues
eng
Pagination
84Informations de copyright
© 2024. The Author(s).
Références
Harris C, Green S, Elshaug AG. Sustainability in Health care by allocating resources effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation. BMC Health Serv Res. 2017;17(1):632.
pubmed: 28886740
pmcid: 5590199
doi: 10.1186/s12913-017-2506-7
Alkhaldi M, Al Basuoni A, Matos M, Tanner M, Ahmed S. Health Technology Assessment in High, Middle, and low-income countries: new systematic and interdisciplinary Approach for Sound informed-policy making: Research Protocole. Risk Manag Healthc Policy. 2021;14:2757–70.
pubmed: 34234591
pmcid: 8254407
doi: 10.2147/RMHP.S310215
Ciani O, Tarricone R, Torbica A. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems? Health Policy. 2012;108(2–3):194–202.
pubmed: 23093020
doi: 10.1016/j.healthpol.2012.09.017
Culyer A, Chalkidou K, Teerawattananon Y, Santatiwongchai B. Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who Decides? Who pays? F1000Res. 2018;7:72.
pubmed: 29904588
doi: 10.12688/f1000research.13284.1
Arab-Zozani M, Sokhanvar M, Kakemam E, Didehban T, Hassanipour S. History of Health Technology Assessment in Iran. Int J Technol Assess Health Care. 2020;36(1):34–9.
pubmed: 31928553
doi: 10.1017/S0266462319003489
Doaee Sh, Olyaeemanesh A, Emami Sh, Mobinizadeh M, Abooee P, Nejati M, et al. Development and implementation of health technology assessment: a policy study. Iran J Public Health. 2013;42(Supple1):50–4.
pubmed: 23865016
Mohtasham F, Yazdizadeh B, Zali Z, Majdzadeh R, Nedjat S. Health technology assessment in Iran: barriers and solutions. Med J Islam Repub Iran. 2016;30:321.
pubmed: 27390691
pmcid: 4898849
Behzadifar M, Behzadifar M, Saran M, Shahabi S, Bakhtiari A, Azari S, et al. The role of Iran’s context for the development of health technology assessment: challenges and solutions. Health Econ Rev. 2023;13(1):23.
pubmed: 37079131
pmcid: 10116738
doi: 10.1186/s13561-023-00438-7
Behzadifar M, Ghanbari MK, Azari S, Bakhtiari A, Rahimi S, Ehsanzadeh SJ, et al. A SWOT analysis of the development of health technology assessment in Iran. PLoS ONE. 2023;18(3):e0283663.
pubmed: 36996128
pmcid: 10062657
doi: 10.1371/journal.pone.0283663
Aryankhesal A, Behzadifar M, Bakhtiari A, Shahabi S, Azari S, Darvishi Teli B, et al. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply. Health Res Policy Syst. 2024;22(1):11.
pubmed: 38225573
pmcid: 10789076
doi: 10.1186/s12961-023-01097-0
Doshmangir L, Behzadifar M, Shahverdi A, Martini M, Ehsanzadeh SJ, Azari S, et al. Analysis and evolution of health policies in Iran through policy triangle framework during the last thirty years: a systematic review of the historical period from 1994 to 2021. J Prev Med Hyg. 2023;64(1):E107–17.
pubmed: 37293450
pmcid: 10246607
Khankeh HR, Bagheri Lankarani K, Zarei N, Joulaei H. Three decades of Healthcare System Reform in Iran from the perspective of Universal Health Coverage: a macro-qualitative study. Iran J Med Sci. 2021;46(3):198–206.
Olyaeemanesh A, Doaee S, Mobinizadeh M, Nedjati M, Aboee P, Emami-Razavi SH. Health technology assessment in Iran: challenges and views. Med J Islam Repub Iran. 2014;28:157.
pubmed: 25695015
pmcid: 4322330
Fanourgiakis J, Kanoupakis E. Health technology assessment (HTA): a brief introduction of history and the current status in the field of cardiology under the economic crisis. J Evid Based Med. 2015;8(3):161–4.
pubmed: 26291523
doi: 10.1111/jebm.12171
Hollingworth S, Fenny AP, Yu SY, Ruiz F, Chalkidou K. Health technology assessment in sub-saharan Africa: a descriptive analysis and narrative synthesis. Cost Eff Resour Alloc. 2021;19(1):39.
pubmed: 34233710
pmcid: 8261797
doi: 10.1186/s12962-021-00293-5
Noorani HZ, Husereau DR, Boudreau R, Skidmore B. Priority setting for health technology assessments: a systematic review of current practical approaches. Int J Technol Assess Health Care. 2007;23(3):310–5.
pubmed: 17579932
doi: 10.1017/S026646230707050X
Husereau D, Boucher M, Noorani H. Priority setting for health technology assessment at CADTH. Int J Technol Assess Health Care. 2010;26(3):341–7.
pubmed: 20584365
doi: 10.1017/S0266462310000383
Staniszewska S, Söderholm Werkö S. Mind the evidence gap: the use of patient-based evidence to create complete HTA in the twenty-first century. Int J Technol Assess Health Care. 2021;37:e46.
pubmed: 33745475
doi: 10.1017/S026646232100012X
Gagnon MP, Tantchou Dipankui M, Poder TG, Payne-Gagnon J, Mbemba G, Beretta V. Patient and public involvement in health technology assessment: update of a systematic review of international experiences. Int J Technol Assess Health Care. 2021;37:e36.
pubmed: 33541449
doi: 10.1017/S0266462321000064
Ciani O, Wilcher B, Blankart CR, Hatz M, Rupel VP, Erker RS, et al. Health technology assessment of medical devices: a survey of non-european union agencies. Int J Technol Assess Health Care. 2015;31(3):154–65.
pubmed: 26044729
pmcid: 4535322
doi: 10.1017/S0266462315000185
Falkowski A, Ciminata G, Manca F, Bouttell J, Jaiswal N, Farhana Binti Kamaruzaman H, et al. How least developed to Lower-Middle Income Countries Use Health Technology Assessment: a scoping review. Pathog Glob Health. 2023;117(2):104–19.
pubmed: 35950264
doi: 10.1080/20477724.2022.2106108
Kim T, Sharma M, Teerawattananon Y, Oh C, Ong L, Hangoma P, et al. Addressing challenges in Health Technology Assessment Institutionalization for Furtherance of Universal Health Coverage through South-South Knowledge Exchange: lessons from Bhutan, Kenya, Thailand, and Zambia. Value Health Reg Issues. 2021;24:187–92.
pubmed: 33838558
pmcid: 8163602
doi: 10.1016/j.vhri.2020.12.011
Al-Harakeh L, Abbas H, Hassan H, Hallal Z, Hamadeh G, Kurdi M, et al. Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon. Int J Technol Assess Health Care. 2021;37(1):e72.
pubmed: 34193326
doi: 10.1017/S026646232100043X
Hollingworth SA, Ruiz F, Gad M, Chalkidou K. Health technology assessment capacity at national level in sub-saharan Africa: an initial survey of stakeholders. F1000Res. 2020;9:364.
pubmed: 32595957
doi: 10.12688/f1000research.23263.1
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, et al. Real-world data and evidence in health technology assessment: when are they complementary, substitutes, or the only sources of data compared to clinical trials? Therapie. 2023;78(1):81–94.
pubmed: 36464522
doi: 10.1016/j.therap.2022.11.001
Downey L, Rao N, Guinness L, Asaria M, Prinja S, Sinha A, et al. Identification of publicly available data sources to inform the conduct of Health Technology Assessment in India. F1000Res. 2018;7:245.
pubmed: 29770210
pmcid: 5930391
doi: 10.12688/f1000research.14041.1
Yazdizadeh B, Mohtasham F, Velayati A. Impact assessment of Iran’s health technology assessment programme. Health Res Policy Syst. 2018;16(1):15.
pubmed: 29471838
pmcid: 5824575
doi: 10.1186/s12961-018-0286-0
Trowman R, Migliore A, Ollendorf DA. Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment. Int J Technol Assess Health Care. 2023;39(1):e15.
pubmed: 36815310
doi: 10.1017/S0266462323000090
Zimmermann G, Michelmore S, Hiligsmann M. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains. Int J Technol Assess Health Care. 2023;39(1):e29.
pubmed: 37212049
doi: 10.1017/S0266462323000077
Wong J. The History of Technology Assessment and Comparative Effectiveness Research for Drugs and Medical Devices and the role of the Federal Government. Biotechnol Law Rep. 2014;33(6):221–48.
pubmed: 25538377
pmcid: 4270161
doi: 10.1089/blr.2014.9967
Wilkinson M, Gray AL, Wiseman R, Kredo T, Cohen K, Miot J, et al. Health Technology Assessment in Support of National Health Insurance in South Africa. Int J Technol Assess Health Care. 2022;38(1):e44.
pubmed: 35513309
doi: 10.1017/S0266462322000265
Wale JL, Thomas S, Hamerlijnck D, Hollander R. Patients and public are important stakeholders in health technology assessment but the level of involvement is low - a call to action. Res Involv Engagem. 2021;57(1):1.
doi: 10.1186/s40900-020-00248-9
Vervoort D, Tam DY, Wijeysundera HC. Health Technology Assessment for Cardiovascular Digital Health Technologies and Artificial Intelligence: why is it different? Can J Cardiol. 2022;38(2):259–66.
pubmed: 34461229
doi: 10.1016/j.cjca.2021.08.015
Vella Bonanno P, Bucsics A, Simoens S, Martin AP, Oortwijn W, Gulbinovič J, et al. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA. Expert Rev Pharmacoecon Outcomes Res. 2019;19(3):251–61.
pubmed: 30696372
doi: 10.1080/14737167.2019.1575730
Uzochukwu BSC, Okeke C, O’Brien N, Ruiz F, Sombie I, Hollingworth S. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria. Global Health. 2020;16(1):58.
pubmed: 32641066
pmcid: 7346669
doi: 10.1186/s12992-020-00583-2
Stühlinger V. Health Technology Assessment (HTA) and Access policies. Eur J Health Law. 2020;27(3):274–89.
pubmed: 33652403
doi: 10.1163/15718093-BJA10006
Soárez PC. Health Technology Assessment: informed by science or in the service of politics? Rev Saude Publica. 2021;55:64.
pubmed: 34706040
pmcid: 8522711
doi: 10.11606/s1518-8787.2021055003234
Simões Corrêa Galendi J, Caramori CA, Lemmen C, Müller D, Stock S. Expectations for the Development of Health Technology Assessment in Brazil. Int J Environ Res Public Health. 2021;18(22):11912.
pubmed: 34831668
pmcid: 8625173
doi: 10.3390/ijerph182211912
Sharma M, Teerawattananon Y, Dabak SV, Isaranuwatchai W, Pearce F, Pilasant S, et al. A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region. Health Res Policy Syst. 2021;19(1):19.
pubmed: 33573676
pmcid: 7879649
doi: 10.1186/s12961-020-00647-0
Rozmovits L, Mai H, Chambers A, Chan K. What does meaningful look like? A qualitative study of patient engagement at the Pan-canadian Oncology Drug Review: perspectives of reviewers and payers. J Health Serv Res Policy. 2018;23(2):72–9.
pubmed: 29624087
doi: 10.1177/1355819617750686
Ramponi F, Twea P, Chilima B, Nkhoma D, Kazanga Chiumia I, Manthalu G, et al. Assessing the potential of HTA to inform resource allocation decisions in low-income settings: the case of Malawi. Front Public Health. 2022;10:1010702.
pubmed: 36388387
pmcid: 9650047
doi: 10.3389/fpubh.2022.1010702
Prevolnik Rupel V. Current implementation of health technology assessment in healthcare system in Slovenia. Int J Technol Assess Health Care. 2017;33(3):360–4.
pubmed: 28434423
doi: 10.1017/S0266462317000083
Oortwijn W, van Oosterhout S, Kapiriri L. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries. Int J Technol Assess Health Care. 2020;27:1–5.
Oortwijn W, Mathijssen J, Banta D. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Health Policy Plan. 2010;95(2–3):174–84.
doi: 10.1016/j.healthpol.2009.12.008
Oortwijn W, Jansen M, Baltussen R. Use of evidence-informed deliberative processes by Health Technology Assessment Agencies around the Globe. Int J Health Policy Manag. 2020;9(1):27–33.
pubmed: 31902192
doi: 10.15171/ijhpm.2019.72
MacQuilkan K, Baker P, Downey L, Ruiz F, Chalkidou K, Prinja S, et al. Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa. Glob Health Action. 2018;11(1):1527556.
pubmed: 30326795
pmcid: 6197020
doi: 10.1080/16549716.2018.1527556
Lehoux P, Blume S. Technology assessment and the sociopolitics of health technologies. J Health Polit Policy Law. 2000;25(6):1083–120.
pubmed: 11142053
doi: 10.1215/03616878-25-6-1083
Husereau D, Henshall C, Sampietro-Colom L, Thomas S. Changing health technology assessment paradigms? Int J Technol Assess Health Care. 2016;32(4):191–9.
pubmed: 27766998
doi: 10.1017/S0266462316000386